Table Of Contents
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size by Component Type
2.3.2 Market Size by Cancer Type
2.3.3 Market Size by Application
2.3.4 Market Size by End Use
2.4 Market Share & Bps Analysis by Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Data, Technology & Infrastructure Providers
3.4.2 AI Oncology Solution Developers
3.4.3 Healthcare IT Integrators & Distribution Partners
3.4.4 Healthcare Providers & Research Institutions
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 Cancer Incidence & Oncology Burden Trends (2025)
4.1.1 Global Cancer Prevalence & Incidence Statistics
4.1.2 Mortality & Survival Rate Trends by Cancer Type
4.1.3 High-Burden Cancer Type Analysis
4.1.4 Regional Cancer Burden Assessment
4.2 AI Adoption in Oncology Trends (2025)
4.2.1 Global AI in Oncology Deployment Statistics
4.2.2 AI Adoption Across Diagnosis, Treatment & Research
4.2.3 Hospital & Cancer Center AI Utilization Trends
4.2.4 Clinical Workflow Integration Analysis
4.3 Medical Imaging & Diagnostic AI Trends (2025)
4.3.1 AI-Assisted Cancer Imaging Volume Trends
4.3.2 Radiology & Pathology AI Adoption Statistics
4.3.3 Early Cancer Detection Performance Analysis
4.3.4 Precision Diagnostics & Biomarker Identification Trends
4.4 Precision Medicine & Drug Discovery Trends (2025)
4.4.1 Genomic Data Utilization in Oncology AI Applications
4.4.2 AI-Driven Drug Discovery & Development Trends
4.4.3 Companion Diagnostics Adoption Analysis
4.4.4 Personalized Treatment Planning Trends
4.5 Technology, Investment & Regulatory Trends (2025)
4.5.1 AI Algorithm Innovation & Model Development Trends
4.5.2 Oncology AI Funding & Investment Activity
4.5.3 Strategic Partnerships & Research Collaborations
4.5.4 Regulatory Approvals & Compliance Trends for AI-Based Oncology Solutions
5. AI in Oncology Market Segmental Analysis & Forecast, By Component Type, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Software Solutions
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 Hardware
5.4 Services
6. AI in Oncology Market Segmental Analysis & Forecast, By Cancer Type, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Breast Cancer
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Lung Cancer
6.4 Prostate Cancer
6.5 Colorectal Cancer
6.6 Brain Tumor
6.7 Others
7. AI in Oncology Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Diagnostics
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Radiation Therapy
7.4 Research & Development
7.5 Chemotherapy
7.6 Immunotherapy
8. AI in Oncology Market Segmental Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 Surgical Centers & Medical Institutes
8.4 Others
9. AI in Oncology Market Segmental Analysis & Forecast by Region, 2022–2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 AI in Oncology Market Size & Forecast, By Component Type, 2022–2035
9.2.3 AI in Oncology Market Size & Forecast, By Cancer Type, 2022–2035
9.2.4 AI in Oncology Market Size & Forecast, By Application, 2022–2035
9.2.5 AI in Oncology Market Size & Forecast, By End Use, 2022–2035
9.2.6 AI in Oncology Market Size & Forecast, By Country, 2022–2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 AI in Oncology Market Size & Forecast, By Component Type, 2022–2035
9.3.3 AI in Oncology Market Size & Forecast, By Cancer Type, 2022–2035
9.3.4 AI in Oncology Market Size & Forecast, By Application, 2022–2035
9.3.5 AI in Oncology Market Size & Forecast, By End Use, 2022–2035
9.3.6 AI in Oncology Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 AI in Oncology Market Size & Forecast, By Component Type, 2022–2035
9.4.3 AI in Oncology Market Size & Forecast, By Cancer Type, 2022–2035
9.4.4 AI in Oncology Market Size & Forecast, By Application, 2022–2035
9.4.5 AI in Oncology Market Size & Forecast, By End Use, 2022–2035
9.4.6 AI in Oncology Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 AI in Oncology Market Size & Forecast, By Component Type, 2022–2035
9.5.3 AI in Oncology Market Size & Forecast, By Cancer Type, 2022–2035
9.5.4 AI in Oncology Market Size & Forecast, By Application, 2022–2035
9.5.5 AI in Oncology Market Size & Forecast, By End Use, 2022–2035
9.5.6 AI in Oncology Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 AI in Oncology Market Size & Forecast, By Component Type, 2022–2035
9.6.3 AI in Oncology Market Size & Forecast, By Cancer Type, 2022–2035
9.6.4 AI in Oncology Market Size & Forecast, By Application, 2022–2035
9.6.5 AI in Oncology Market Size & Forecast, By End Use, 2022–2035
9.6.6 AI in Oncology Market Size & Forecast, By Country, 2022–2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2022–2025
10.2.3 Number of Strategies Adopted by Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features by Key Players
10.4.2 Product/Service Heatmap by Key Players
10.4.3 Application Heatmap by Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Azra AI
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 IBM
10.6.3 Siemens Healthcare GmbH
10.6.4 Intel Corporation
10.6.5 GE HealthCare
10.6.6 NVIDIA Corporation
10.6.7 Digital Diagnostics Inc.
10.6.8 ConcertAI
10.6.9 Median Technologies
10.6.10 PathAI
10.6.11 MVision AI
10.6.12 Tempus AI
10.6.13 Paige AI
10.6.14 Lunit Inc.
10.6.15 Qure.ai
10.6.16 iCAD, Inc.
10.6.17 Volpara Health Technologies
10.6.18 Owkin
10.6.19 Freenome
10.6.20 Deep Bio
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List of Tables
14.2 List of Figures
Frequently Asked Questions
The AI in Oncology Market is expected to grow at a CAGR of 26.23% from 2026 to 2035.
Rising complexity in cancer care, growing adoption of personalized treatment approaches, and increasing demand for quick, accurate diagnosis are the key factors driving growth in the AI in Oncology Market.
The AI in Oncology Market was valued at USD 4.43 Billion in 2025.
North America dominated the AI in Oncology Market in 2025.
Data privacy is a major hurdle, with 85% of healthcare leaders identifying HIPAA and GDPR compliance as barriers to implementing AI at scale.